NCT01572662
- Conditions
- Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +39 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Neoplasms, Plasma Cell
Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.
2,606 public trials
547 recruiting studies
Neoplasms, Plasma Cell trial results
Completed
Revlimid And Prednisone Followed By Revlimid, Melphalan And Prednisone In Multiple Myeloma Patients
NCT01160107
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease, +15 more
- Locations
-
Not specified
NCT01166113
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
- Locations
-
- AOU Città della Salute e della Scienza di Torino - SC Ematologia U Torino, Italy
NCT01348919
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Teva Investigational Site 1 Augusta, Georgia, United States
- Teva Investigational Site 3 Lexington, Kentucky, United States
- Teva Investigational Site 2 Houston, Texas, United States
- Teva Investigational Site 201 Auckland, New Zealand
NCT05448196
- Conditions
- Behavior, Behavioral Symptoms, Blood Protein Disorders, +16 more
- Locations
-
- Penn Medicine Philadelphia, Pennsylvania, United States
NCT03364231
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +19 more
- Locations
-
- TG Therapeutics Investigational Trial Site Washington D.C., District of Columbia, United States
- TG Therapeutics Investigational Trial Site Boston, Massachusetts, United States
- TG Therapeutics Investigational Trial Site Hackensack, New Jersey, United States
- TG Therapeutics Investigational Trial Site New York, United States
NCT00458653
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute/Brigham & Women's Hospital Boston, Massachusetts, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- Rambam Medical Center Haifa, Israel
Completed
CART-19 for Multiple Myeloma
NCT02135406
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
- Locations
-
- Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States
NCT00003615
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +27 more
- Locations
-
- Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- CCOP - Southern Nevada Cancer Research Foundation Las Vegas, Nevada, United States
- Trinitas Hospital - Jersey Street Campus Elizabeth, New Jersey, United States
Completed
VMP Regimen - Safety, Efficacy, and Optimal Dose Finding Study for Patients With Multiple Myeloma
NCT04151615
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Soonchunhyang University Bucheon hospital Bucheon-si, South Korea
- Inje university Haeundae Paik Hospital Busan, South Korea
- Kosin University Gospel hospital Busan, South Korea
- Pusan national University Hospital Busan, South Korea